End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
286,000 KRW | +1.78% |
|
+6.92% | +190.36% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ALTEOGEN INC. | Biopharmaceuticals | +1.78% | +6.92% | +190.36% | +576.92% | +2,588.25% | 10.96B | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- A196170 Stock
- Charts ALTEOGEN Inc.
- Comparison Chart